Impact of lisinopril on cardiometabolic risk factors in sisters of women with polycystic ovary syndrome.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.2268
Abstract: Women with polycystic ovary syndrome (PCOS), the most common endocrinopathy in reproductive age, are characterized by increased cardiometabolic risk. Similar hormonal and metabolic changes were found in their siblings. The purpose of our study was… read more here.
Keywords: polycystic ovary; ovary syndrome; women polycystic; sisters women ... See more keywords